Keir, H., Long, M., Abo-Leyah, H., Giam, Y., Vadiveloo, T., Pembridge, T., Hull, R., Delgado, L., Band, M., McLaren-Neil, F., Adamson, S., Lahnsteiner, E., Gilmour, A., Hughes, C., New, B., Connell, D., Dowey, R., Turton, H., Richardson, H., Cassidy, D., Cooper, J., Suntharalingam, J., Diwakar, L., Russell, P., Underwood, J., Hicks, A., Dosanjh, D., Sage, B., Dhasmana, D., Spears, M., Thompson, A., Brightling, C., Smith, A., Patel, M., George, J., Condliffe, A., Shoemark, A., Chalmers, J. & STOP-COVID19 Investigators 2022, 'Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial', The Lancet Respiratory Medicine, 10(12), pp. 1119-1128. https://doi.org/10.1016/S2213-2600(22)00261-2